Early Forms of Oxidized LDL, TLRs and Atherosclerosis
Early Forms of Oxidized LDL, TLRs and Atherosclerosis
批准号:
7839765
负责人:
Yury Miller
金额:
$23.8万
依托单位国家:
美国
项目类别:
财政年份:
2009
资助国家:
美国
项目状态:
已结题
起止时间:
2009-07-15 至 2011-06-30
关键词:
Animal ModelArterial Fatty StreakAtherosclerosisAutoantigensBindingBiologicalBloodCD14 geneCardiovascular DiseasesCell Culture TechniquesChronicComplexCytokine SignalingDNA Sequence RearrangementDataDevelopmentEnvironmental Risk FactorEventF-ActinGene ExpressionGenesImmune responseImmunohistochemistryImmunologic ReceptorsIn VitroIndividualInflammationInflammatoryInflammatory ResponseLesionLigandsLipidsLipopolysaccharidesLipoprotein (a)Lipoprotein BindingLow Density Lipoprotein oxidationLow-Density LipoproteinsMacrophage ActivationMediatingMembraneMinimally modified Low Density LipoproteinModificationPathway interactionsPhosphatidylinositolsPhosphotransferasesPlasmaProteinsPublishingReceptor ActivationReceptor SignalingReportingResearch PersonnelReverse Transcriptase Polymerase Chain ReactionRiskRisk FactorsRoleSignal PathwaySignal TransductionStaining methodStainsSurfaceTestingTimeToll-like receptorscytokinein vivolaser capture microdissectionmacrophagemicrobialoxidationoxidized low density lipoproteinpathogenreceptorresponsetoll-like receptor 4
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Oxidative modification of LDL is an important, if not obligatory, step that mediates the atherogenicity ofLDL.
Many pathological conditions and environmental factors promote LDL oxidation, especially formation of
early forms of oxidized LDL,termed minimally modified LDL (mmLDL). In addition to established presence
of oxidized LDL in atherosclerotic lesions, recent reports find early oxidized forms of LDL even in the blood
of apparently healthy individuals, and elevated levels in people with cardiovasculardisease. This proposal
will examine my hypothesis that mmLDL promotes inflammation in atherosclerotic lesions via modulation of
Toll-like receptor (TLR) signaling. This hypothesis has been supported by our recently published findings
that mmLDL, but not extensively oxidized LDL,binds to CD14 and that this complex activates TLR4,
resulting in cytoskeletal rearrangements and pro-inflammatory signaling and cytokine expression. In
addition, our preliminary data demonstrate that mmLDL augments LPS-induced cytokine secretion by
macrophages in vitro. CD14 and TLR4 are crucial innate immune receptors that sense bacterial LPS.The
existence of mmLDL signaling through CD14/TLR4 suggests convergence of immune responses to
oxidation-specific self-antigens and to microbial pathogens. I propose the following Specific Aims for this
project: 1) To test the hypothesis that mmLDL induces specific clustering of TLR4 with other receptors on
the surface of macrophages, thereby initiating a unique intracellular signaling cascade. 2) To test the
hypothesis that a unique set of pro-inflammatory genes expressed and secreted in response to mmLDL is a
result of a crosstalk between TLR4-dependent and independent signaling pathways. 3) To test the
hypothesis that mmLDL augments pro-inflammatory gene expression induced by LPS and other TLR
ligands in animal models of inflammation. 4) To test the hypothesis that mmLDL promotes TLR-dependent
inflammation in atherosclerotic lesions. Further development of my hypothesis will help elucidate
mechanisms of chronic inflammation in development of atherosclerosis and better understand how
particular microbial pathogens increase the risk of atherosclerotic complications. Because the oxidized
moieties in mmLDL are likely to be common components of oxidized membranes in general, these studies
are likely to have generalized importance.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
AIBP and regulation of neuropathic pain
-
批准号:9816541
-
项目类别:
-
资助金额:$78.73万
-
财政年份:2019
-
负责人:Yury Miller
-
依托单位:
Reversal of preexisting neuropathic pain by spinal delivery of AIBP
-
批准号:9750836
-
项目类别:
-
资助金额:$36.99万
-
财政年份:2018
-
负责人:Yury Miller
-
依托单位:
Reversal of preexisting neuropathic pain by spinal delivery of AIBP
-
批准号:10197482
-
项目类别:
-
资助金额:$37.67万
-
财政年份:2018
-
负责人:Yury Miller
-
依托单位:
Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis
-
批准号:10188606
-
项目类别:
-
资助金额:$35.12万
-
财政年份:2017
-
负责人:Yury Miller
-
依托单位:
AIBP therapy
-
批准号:9240927
-
项目类别:
-
资助金额:$93.0万
-
财政年份:2017
-
负责人:Yury Miller
-
依托单位:
AIBP therapy
-
批准号:10551912
-
项目类别:
-
资助金额:$93.0万
-
财政年份:2017
-
负责人:Yury Miller
-
依托单位:
AIBP therapy
-
批准号:10331313
-
项目类别:
-
资助金额:$93.0万
-
财政年份:2017
-
负责人:Yury Miller
-
依托单位:
Project 2: Cholesterol Regulation of Inflammatory Macrophages in Atherosclerosis
-
批准号:10334095
-
项目类别:
-
资助金额:$4.3万
-
财政年份:2017
-
负责人:Yury Miller
-
依托单位:
AIBP and Endothelial Function
-
批准号:8885205
-
项目类别:
-
资助金额:$51.56万
-
财政年份:2015
-
负责人:Yury Miller
-
依托单位:
AIBP and Endothelial Function
-
批准号:9039657
-
项目类别:
-
资助金额:$51.96万
-
财政年份:2015
-
负责人:Yury Miller
-
依托单位:
Zebrafish models of vascular inflammation and atherosclerosis
-
批准号:8320140
-
项目类别:
-
资助金额:$41.95万
-
财政年份:2009
-
负责人:Yury Miller
-
依托单位:
Zebrafish models of vascular inflammation and atherosclerosis
-
批准号:8485638
-
项目类别:
-
资助金额:$40.06万
-
财政年份:2009
-
负责人:Yury Miller
-
依托单位:
Zebrafish models of vascular inflammation and atherosclerosis
-
批准号:7923970
-
项目类别:
-
资助金额:$41.26万
-
财政年份:2009
-
负责人:Yury Miller
-
依托单位:
Zebrafish models of vascular inflammation and atherosclerosis
-
批准号:8145544
-
项目类别:
-
资助金额:$41.76万
-
财政年份:2009
-
负责人:Yury Miller
-
依托单位:
Zebrafish models of vascular inflammation and atherosclerosis
-
批准号:7688282
-
项目类别:
-
资助金额:$45.77万
-
财政年份:2009
-
负责人:Yury Miller
-
依托单位:
Morphology and Imaging Core
-
批准号:8840307
-
项目类别:
-
资助金额:$24.43万
-
财政年份:2008
-
负责人:Yury Miller
-
依托单位:
Morphology Core
-
批准号:7456195
-
项目类别:
-
资助金额:$29.49万
-
财政年份:2008
-
负责人:Yury Miller
-
依托单位:
Morphology and Imaging Core
-
批准号:8703256
-
项目类别:
-
资助金额:$24.62万
-
财政年份:2008
-
负责人:Yury Miller
-
依托单位:
Early Forms of Oxidized LDL, TLRs and Atherosclerosis
-
批准号:7216749
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Yury Miller
-
依托单位:
Early Forms of Oxidized LDL, TLRs and Atherosclerosis
-
批准号:7789573
-
项目类别:
-
资助金额:$37.5万
-
财政年份:2006
-
负责人:Yury Miller
-
依托单位: